Revenue Memorandum Circulars Revenue Memo Circular No. 1-2023
BIR
Bureau of Internal Revenue
Administrative issuances
520 issuances
Revenue Memorandum Circulars Revenue Memorandum Circular No. 8-2023
Revised Provision on the Submission of Inventory List and Other Reporting Requirements Pursuant to Revenue Memorandum Circular No. 57-2015
Revenue Memorandum Circulars Revenue Memo Circular No. 157-2022
Publishing the Full Text of the November 28, 2022 Letter from the Food and Drug Administration (FDA) of the Department of Health (DOH) Endorsing Updates to the List of VAT-Exempt Medicines Under Republic Act (R.A.) No. 11534 Known as the Corporate Recover and Tax Incentives for Enterprises (CREATE) Act
Revenue Memorandum Orders Revenue Memo Order No. 58-2022
Policies, Guidelines and Procedures in the Processing and Monitoring of One-TimeTransactions (ONETT) thru the ONETT Tracking System (OTS)
Revenue Memorandum Orders Revenue Memorandum Order No. 55-2022
Suspension of All Audit and Other Field Operations of the Bureau of Internal Revenue Effective December 16, 2022
Revenue Memorandum Circulars Revenue Memo Circular No. 154-2022
Superseding the Provisions of RMC No. 142-2019 Circularizing the Electronic Documentary Stamp Tax (eDST) System's Balance Adjustment Facility as an Option for Recovery of Erroneously Deducted DST
Revenue Memorandum Orders Revenue Memo Order No. 57-2022
Further Amending RMO Nos. 9-95 and 17- 2012, as Amended, on the Submission and Report Format of the BIR Form No. 1209 (Consolidated Monthly Statistical Report of Revenue Collections)
Revenue Memorandum Circulars Revenue Memorandum Circular No. 151-2022
Circularizing the Updated List of Accredited Microfinance Non-Government Organizations (NGOs)
Revenue Memorandum Circulars Revenue Memorandum Circular No. 153-2022
Availability of the BIR Online Registration and Update System (ORUS)
Revenue Memorandum Circulars Revenue Memo Circular No. 156-2022
Publishing the Full Text of the November 23, 2022 Letter from the Food and Drug Administration (FDA) of the Department of Health (DOH) Endorsing Updates to the List of VAT-Exempt Medicines Under Republic Act (R.A.) No. 11534 Known as the Corporate Recover and Tax Incentives for Enterprises (CREATE) Act
Revenue Memorandum Circulars Revenue Memo Circular No. 152-2022
Clarifies Further the Transitory Provisions for the VAT Zero-Rate Incentives Under Sections 294(E) and 295(D), Title XIII of the Tax Code, as amended, and as Implemented by Section 5, Rule 2 and Section 5 Rule 18 of the CREATE Act Implementing Rules and Regulations (CREATE IRR)
Revenue Memorandum Orders Revenue Memorandum Order No. 6-2023